Sheng Yang

Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies.

T. Wang, D. Zhong, Yanqiu Zhao, 2023, Lung cancer.

Current evidences on vascular endothelial growth factor polymorphisms and breast cancer susceptibility

Lei Yao, Si Sun, C. Mao, 2011, Molecular Biology Reports.

Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis

C. Mao, Wei Zheng, W. Cai, 2011, Breast Cancer Research and Treatment.